FMC CTO Kathleen Shelton to retire Mar 31; Seva Rostovtsev appointed as successor

FMC CORP

Dr. Kathleen Shelton to retire as EVP and CTO effective March 31, 2023, after 33-year career.
Dr. Seva Rostovtsev, currently director of Discovery Chemistry, named VP and CTO effective April 1, 2023.
Rostovtsev was co-inventor of copper-catalyzed Click Chemistry, awarded 2022 Nobel Prize in Chemistry.
Shelton led an innovation pipeline valued at over $2.5 billion in peak sales from new products.
Rostovtsev will report to CEO Mark Douglas and join the company's Operating Committee.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Kathleen Shelton

Executive Vice President and Chief Technology Officer

FMC · FMC CORP

Effective: 2023-03-31
Filed: December 14, 2022, 6:59 PM ET

On December 14, 2022, FMC Corporation (“FMC” or the “Company”) announced that Dr. Kathleen Shelton will retire from her position as Executive Vice President and Chief Technology Officer (“CTO”) of the Company effective March 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Kathleen Shelton departed as Executive Vice President and Chief Technology Officer at FMC CORP.

Action: retire
Role: Executive Vice President and Chief Technology Officer

Exact text from the filing

On December 14, 2022, FMC Corporation (“FMC” or the “Company”) announced that Dr. Kathleen Shelton will retire from her position as Executive Vice President and Chief Technology Officer (“CTO”) of the Company effective March 31, 2023.

View on SEC.gov

FMC CORP filing history →

Source: SEC EDGAR

accession 0000037785-22-000097

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.